Nuveen Asset Management’s Entrada Therapeutics TRDA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $1.51M | Sell |
87,506
-42,360
| -33% | -$732K | ﹤0.01% | 2500 |
|
|
2024
Q3 | $2.08M | Buy |
129,866
+7,004
| +6% | +$112K | ﹤0.01% | 2393 |
|
|
2024
Q2 | $1.75M | Buy |
122,862
+65,725
| +115% | +$937K | ﹤0.01% | 2450 |
|
|
2024
Q1 | $810K | Sell |
57,137
-23,373
| -29% | -$331K | ﹤0.01% | 2780 |
|
|
2023
Q4 | $1.21M | Buy |
80,510
+7,148
| +10% | +$108K | ﹤0.01% | 2645 |
|
|
2023
Q3 | $1.16M | Buy |
73,362
+16,548
| +29% | +$261K | ﹤0.01% | 2519 |
|
|
2023
Q2 | $860K | Buy |
56,814
+43,827
| +337% | +$664K | ﹤0.01% | 2710 |
|
|
2023
Q1 | $188K | Buy |
+12,987
| New | +$188K | ﹤0.01% | 2998 |
|
|
2022
Q2 | – | Sell |
-13,872
| Closed | -$130K | – | 3395 |
|
|
2022
Q1 | $130K | Hold |
13,872
| – | – | ﹤0.01% | 3230 |
|
|
2021
Q4 | $237K | Buy |
+13,872
| New | +$237K | ﹤0.01% | 3217 |
|